Finance

Lists
ORX:STO
Orexo AB
SEK 1.37
-1.58%
(-0.022) 1D
Nov 6, 5:29:49 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ORX...
Open
SEK 1.47
High
SEK 1.47
Low
SEK 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEK 36.00
52-wk low
SEK 1.30
EPS
SEK 21.73
Shares outstanding
35.13M
No. of employees
55
Open
SEK 1.47
High
SEK 1.47
Low
SEK 1.31
Mkt. cap
48.05M
Avg. vol.
320.60K
Volume
525.28K
P/E ratio
0.06
52-wk high
SEK 36.00
52-wk low
SEK 1.30
EPS
SEK 21.73
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.30M
5.00M
3.50M
800.00K
Cost of goods sold
2.60M
500.00K
100.00K
100.00K
Cost of revenue
2.60M
500.00K
100.00K
100.00K
Research and development expenses
55.60M
50.10M
53.40M
54.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.00M
37.40M
58.20M
15.90M
Operating expense
80.70M
80.20M
106.50M
62.20M
Total operating expenses
83.30M
80.70M
106.60M
62.30M
Operating income
-80.00M
-75.70M
-103.10M
-61.50M
Other non operating income
-200.00K
-100.00K
-300.00K
100.00K
EBT including unusual items
-115.50M
-104.20M
-102.30M
-95.80M
EBT excluding unusual items
-93.50M
-104.50M
-103.00M
-61.20M
Income tax expense
100.00K
1.00M
200.00K
22.10M
Effective tax rate
-0.09%
-0.96%
-0.20%
-23.07%
Other operating expenses
-2.90M
-7.30M
-5.10M
-7.80M
Net income
724.80M
-133.90M
-100.40M
-96.40M
Net profit margin
21,963.64%
-2,678.00%
-2,868.57%
-12,050.00%
Earnings per share
-
-
-2.53
-
Interest and investment income
600.00K
4.40M
2.00M
1.30M
Interest expense
-12.20M
-32.90M
-
-
Net interest expenses
-11.60M
-28.50M
2.00M
1.30M
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.80M
-66.90M
-94.90M
-53.40M
Gain or loss from assets sale
-
-
-
300.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps